Publication

Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma

Journal Paper/Review - Oct 15, 2000

Heinzerling Lucie, Urbanek M, Funk J O, Peker S, Bleck O, Neuber K, Burg G, von Den Driesch P, Dummer R